Search results
4 days ago · SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). Latest Research and Reviews
4 days ago · The cells were incubated with a pool of SARS-CoV-2 spike peptides (GenScript, RP30230) at 0.2 µg per well per peptide for 36 h, with 2 μg ml −1 concanavalin A (Sigma-Aldrich, C2010) and ...
Apr 24, 2024 · Compared with individuals with anxiety or depression categorised as mild (with scores 1–3, n=21), those with the condition categorised as severe (with scores of 4 and 5, n=23) were significantly associated with higher SARS-CoV-2 antisense RNA concentrations (∗p<0·05, t test) and a lower immunometabolism score (∗p<0·05, Mann-Whitney test ...
Apr 24, 2024 · The treatment effect of remdesivir was most pronounced in patients with elevated baseline nucleocapsid antigen levels: the recovery rate ratio was 1.95 (95%CI 1.40-2.71) for levels >245 pg/ml vs 1.04 (95%CI 0.76-1.42) for levels < 245 pg/ml. Remdesivir also accelerated the rate of viral RNA and antigen clearance in blood, and patients whose ...
Apr 17, 2024 · This RT-qPCR assay analyses the E (envelope) and RdRp (RNA-dependent RNA polymerase) genes of SARS-CoV-2 in a single reaction 70. Total RNA isolation. Samples were inactivated by heat shock (30 ...
4 days ago · SARS-CoV-2 is not a direct descendant of SARS-CoV-1. Genome Genome organization and viral proteins of SARS-CoV. The SARS-related coronavirus is an enveloped, positive-sense, single-stranded RNA virus. Its genome is about 30 kb, which is one of the largest among RNA viruses. The virus has 14 open reading frames which overlap in some cases.
Jan 12, 2021 · SARS-CoV-2 vaccine (mRNA-LNP, spike protein) is under investigation as an active immunization against COVID-19 caused by the SARS-CoV-2 virus in persons 6 months of age and older. SARS-CoV-2 (COVID-19) vaccine is used to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
